Fortrea Holdings FTRE
NASDAQ FTRE
$21.39 +0.47 (+2.22%)
As of: Oct 14, 2026 · 2:16 PM EDT

Fortrea Holdings (FTRE) Gains from Sales and Divestitures (2024)

Updated

Fortrea Holdings (FTRE) reported Gains from Sales and Divestitures of $3.6 million for Q4 2024.

Analysis

Fortrea Holdings (FTRE) Gains from Sales and Divestitures (2024) Analysis & Trends

For FY2024, Fortrea Holdings posted Gains from Sales and Divestitures of -$19.6 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.64 Bn 35.34 Bn 1.44 Bn
2 Medpace Holdings 17.35 Bn 15.41 Bn 201.64 Mn
3 Charles River Laboratories International 14.63 Bn 13.82 Bn 363.37 Mn
4 Icon 13.19 Bn 10.30 Bn 479.29 Mn
5 Fortrea Holdings 2.03 Bn 1.41 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 723.40 Mn -38.68 Mn 18.44 Mn
7 Evotec SE 504.32 Mn -1.11 Bn -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn
9 MindWalk Holdings 62.81 Mn 26.46 Mn 1.61 Mn
10 Natural Alternatives International 6.81 Mn -21.27 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 3.60 Mn
API Access

Fortrea Holdings Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=FTRE&period=max&api_key=YOUR_API_KEY